.png)
.png)
Professor
Cincinnati Children's Hospital Medical Center
Disclosure(s): Ansun BioPharma: Contracted clinical research; Astellas: Contracted clinical research; GSK: Advisor/Consultant; Merck: Advisor/Consultant, Contracted clinical research; Pfizer: Contracted clinical research; Takeda: Contracted clinical research, Grant/Research Support; Viracor: Grant/Research Support
Lara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is the Director of the Immunocompromised Host Infectious Disases Service and Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and complete her residency in Pediatrics at the Cleveland Clinic. She also completed a fellowship in Pediatric Infectious Diseases at St. Louis Children's Hospital. Dr. Danziger-Isakov is board-certified in Pediatrics and Pediatric Infectious Diseases by the American Board of Pediatrics. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on solid organ and stem cell transplantation. In addition, Dr. Danziger-Isakov participates in clinical trials to evaluate vaccine responses, new infectious disease therapies and new method of detection for infectious diseases.